Cargando…
Author correction to ‘Actively priming autophagic cell death with novel transferrin receptor-targeted nanomedicine for synergistic chemotherapy against breast cancer’ [Acta Pharmaceutica Sinica B 2019; 9(5):1061–1077]
| Autores principales: | , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Elsevier
2020
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7332668/ https://www.ncbi.nlm.nih.gov/pubmed/32642419 http://dx.doi.org/10.1016/j.apsb.2020.03.003 |
| _version_ | 1783553567554011136 |
|---|---|
| author | Mei, Dong Chen, Binlong He, Bing Liu, Haibin Lin, Zhiqiang Lin, Jialiang Zhang, Xiaoyan Sun, Ning Zhao, Libo Wang, Xiaoling Zhang, Qiang |
| author_facet | Mei, Dong Chen, Binlong He, Bing Liu, Haibin Lin, Zhiqiang Lin, Jialiang Zhang, Xiaoyan Sun, Ning Zhao, Libo Wang, Xiaoling Zhang, Qiang |
| author_sort | Mei, Dong |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-7332668 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2020 |
| publisher | Elsevier |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-73326682020-07-07 Author correction to ‘Actively priming autophagic cell death with novel transferrin receptor-targeted nanomedicine for synergistic chemotherapy against breast cancer’ [Acta Pharmaceutica Sinica B 2019; 9(5):1061–1077] Mei, Dong Chen, Binlong He, Bing Liu, Haibin Lin, Zhiqiang Lin, Jialiang Zhang, Xiaoyan Sun, Ning Zhao, Libo Wang, Xiaoling Zhang, Qiang Acta Pharm Sin B Erratum Elsevier 2020-06 2020-03-26 /pmc/articles/PMC7332668/ /pubmed/32642419 http://dx.doi.org/10.1016/j.apsb.2020.03.003 Text en © 2020 Chinese Pharmaceutical Association and Institute of Materia Medica, Chinese Academy of Medical Sciences. Production and hosting by Elsevier B.V. http://creativecommons.org/licenses/by-nc-nd/4.0/ This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/). |
| spellingShingle | Erratum Mei, Dong Chen, Binlong He, Bing Liu, Haibin Lin, Zhiqiang Lin, Jialiang Zhang, Xiaoyan Sun, Ning Zhao, Libo Wang, Xiaoling Zhang, Qiang Author correction to ‘Actively priming autophagic cell death with novel transferrin receptor-targeted nanomedicine for synergistic chemotherapy against breast cancer’ [Acta Pharmaceutica Sinica B 2019; 9(5):1061–1077] |
| title | Author correction to ‘Actively priming autophagic cell death with novel transferrin receptor-targeted nanomedicine for synergistic chemotherapy against breast cancer’ [Acta Pharmaceutica Sinica B 2019; 9(5):1061–1077] |
| title_full | Author correction to ‘Actively priming autophagic cell death with novel transferrin receptor-targeted nanomedicine for synergistic chemotherapy against breast cancer’ [Acta Pharmaceutica Sinica B 2019; 9(5):1061–1077] |
| title_fullStr | Author correction to ‘Actively priming autophagic cell death with novel transferrin receptor-targeted nanomedicine for synergistic chemotherapy against breast cancer’ [Acta Pharmaceutica Sinica B 2019; 9(5):1061–1077] |
| title_full_unstemmed | Author correction to ‘Actively priming autophagic cell death with novel transferrin receptor-targeted nanomedicine for synergistic chemotherapy against breast cancer’ [Acta Pharmaceutica Sinica B 2019; 9(5):1061–1077] |
| title_short | Author correction to ‘Actively priming autophagic cell death with novel transferrin receptor-targeted nanomedicine for synergistic chemotherapy against breast cancer’ [Acta Pharmaceutica Sinica B 2019; 9(5):1061–1077] |
| title_sort | author correction to ‘actively priming autophagic cell death with novel transferrin receptor-targeted nanomedicine for synergistic chemotherapy against breast cancer’ [acta pharmaceutica sinica b 2019; 9(5):1061–1077] |
| topic | Erratum |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7332668/ https://www.ncbi.nlm.nih.gov/pubmed/32642419 http://dx.doi.org/10.1016/j.apsb.2020.03.003 |
| work_keys_str_mv | AT meidong authorcorrectiontoactivelyprimingautophagiccelldeathwithnoveltransferrinreceptortargetednanomedicineforsynergisticchemotherapyagainstbreastcanceractapharmaceuticasinicab20199510611077 AT chenbinlong authorcorrectiontoactivelyprimingautophagiccelldeathwithnoveltransferrinreceptortargetednanomedicineforsynergisticchemotherapyagainstbreastcanceractapharmaceuticasinicab20199510611077 AT hebing authorcorrectiontoactivelyprimingautophagiccelldeathwithnoveltransferrinreceptortargetednanomedicineforsynergisticchemotherapyagainstbreastcanceractapharmaceuticasinicab20199510611077 AT liuhaibin authorcorrectiontoactivelyprimingautophagiccelldeathwithnoveltransferrinreceptortargetednanomedicineforsynergisticchemotherapyagainstbreastcanceractapharmaceuticasinicab20199510611077 AT linzhiqiang authorcorrectiontoactivelyprimingautophagiccelldeathwithnoveltransferrinreceptortargetednanomedicineforsynergisticchemotherapyagainstbreastcanceractapharmaceuticasinicab20199510611077 AT linjialiang authorcorrectiontoactivelyprimingautophagiccelldeathwithnoveltransferrinreceptortargetednanomedicineforsynergisticchemotherapyagainstbreastcanceractapharmaceuticasinicab20199510611077 AT zhangxiaoyan authorcorrectiontoactivelyprimingautophagiccelldeathwithnoveltransferrinreceptortargetednanomedicineforsynergisticchemotherapyagainstbreastcanceractapharmaceuticasinicab20199510611077 AT sunning authorcorrectiontoactivelyprimingautophagiccelldeathwithnoveltransferrinreceptortargetednanomedicineforsynergisticchemotherapyagainstbreastcanceractapharmaceuticasinicab20199510611077 AT zhaolibo authorcorrectiontoactivelyprimingautophagiccelldeathwithnoveltransferrinreceptortargetednanomedicineforsynergisticchemotherapyagainstbreastcanceractapharmaceuticasinicab20199510611077 AT wangxiaoling authorcorrectiontoactivelyprimingautophagiccelldeathwithnoveltransferrinreceptortargetednanomedicineforsynergisticchemotherapyagainstbreastcanceractapharmaceuticasinicab20199510611077 AT zhangqiang authorcorrectiontoactivelyprimingautophagiccelldeathwithnoveltransferrinreceptortargetednanomedicineforsynergisticchemotherapyagainstbreastcanceractapharmaceuticasinicab20199510611077 |